BBC Among Health Care ETFs
End-of-day Nov 11, 2026 · 39 Health care ETFs by Max
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.8% | +3.7% | +11.3% | −13.6% | +17.3% | +49.2% | +148.2% | −2.6% | +77.4% |
| Peer average | +0.3% | −0.5% | +8.6% | +5.8% | +23.7% | +32.3% | +74.0% | +27.4% | — |
| S&P 500 · VOO | +1.3% | −0.9% | −2.4% | −2.1% | +12.3% | +12.8% | +81.3% | +75.3% | — |
$24 of every $1,000 in BBC is Xencor
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XNCRXencor | Healthcare | 2.39% | $238.72 | 19K | $746K |
| 2 | KODKodiak Sciences | Healthcare | 2.37% | $237.14 | 6,859 | $741K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.22% | $221.69 | 13K | $693K |
| 4 | REPLReplimune Group | Healthcare | 1.96% | $195.90 | 26K | $612K |
| 5 | ABCLAbCellera Biologics | Healthcare | 1.78% | $177.69 | 45K | $555K |
| 6 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.58% | $158.31 | 16K | $495K |
| 7 | VRDNViridian Therapeutics | Healthcare | 1.41% | $141.04 | 14K | $441K |
| 8 | SGPSpyGlass Pharma | Healthcare | 1.39% | $138.51 | 13K | $433K |
| 9 | MBXMBX Biosciences | Healthcare | 1.19% | $118.57 | 6,579 | $371K |
| 10 | KYMRKymera Therapeutics | Healthcare | 1.18% | $118.43 | 2,709 | $370K |
| 11 | LBRXLB Pharmaceuticals | Healthcare | 1.18% | $118.16 | 8,218 | $369K |
| 12 | ORKAOruka Therapeutics | Healthcare | 1.17% | $117.08 | 3,342 | $366K |
| 13 | PVLAPalvella Therapeutics | Healthcare | 1.16% | $115.78 | 2,145 | $362K |
| 14 | MANEVeraDermics | Healthcare | 1.15% | $115.45 | 2,431 | $361K |
| 15 | VIRVIR Biotechnology | Healthcare | 1.14% | $114.13 | 27K | $357K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XNCR | Xencor | 2.39% |
| 2 | KOD | Kodiak Sciences | 2.37% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.22% |
| 4 | REPL | Replimune Group | 1.96% |
| 5 | ABCL | AbCellera Biologics | 1.78% |
| 6 | AMLX | Amylyx Pharmaceuticals | 1.58% |
| 7 | VRDN | Viridian Therapeutics | 1.41% |
| 8 | SGP | SpyGlass Pharma | 1.39% |
| 9 | MBX | MBX Biosciences | 1.19% |
| 10 | KYMR | Kymera Therapeutics | 1.18% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |